APA (7th ed.) Citation

Becker, L. M. (2020). Monitoring CDK4/6 inhibitor resistance in metastatic breast cancer patients using liquid biopsy markers.

Chicago Style (17th ed.) Citation

Becker, Lisa Maria. Monitoring CDK4/6 Inhibitor Resistance in Metastatic Breast Cancer Patients Using Liquid Biopsy Markers. Heidelberg, 2020.

MLA (9th ed.) Citation

Becker, Lisa Maria. Monitoring CDK4/6 Inhibitor Resistance in Metastatic Breast Cancer Patients Using Liquid Biopsy Markers. 2020.